GSK plc Buys Back Own Shares
Ticker: GLAXF · Form: 6-K · Filed: Jul 31, 2025 · CIK: 1131399
| Field | Detail |
|---|---|
| Company | Gsk PLC (GLAXF) |
| Form Type | 6-K |
| Filed Date | Jul 31, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: share-buyback, transaction-in-own-shares
TL;DR
GSK bought back its own stock on 7/31/25 via Merrill Lynch.
AI Summary
On July 31, 2025, GSK plc, through its corporate stockbroker Merrill Lynch International, purchased a number of its own ordinary shares. The filing is a report of a foreign private issuer for the month of July 2025.
Why It Matters
Share buybacks can signal management's confidence in the company's valuation and potentially increase earnings per share.
Risk Assessment
Risk Level: low — This filing is a routine report of share transactions and does not contain significant new financial or strategic information.
Key Players & Entities
- GSK plc (company) — Registrant
- Merrill Lynch International (company) — Corporate stockbroker for share purchases
- July 31, 2025 (date) — Date of share purchase
FAQ
What specific number of GSK plc ordinary shares were purchased on July 31, 2025?
The filing states that a 'number' of shares were purchased, but the exact quantity is not specified in the provided text.
Who acted as GSK plc's corporate stockbroker for this transaction?
Merrill Lynch International acted as GSK plc's corporate stockbroker for the purchase of its own shares.
What is the principal executive office address of GSK plc?
The principal executive office of GSK plc is located at 79 New Oxford Street, London, WC1A 1DG.
What is the SEC file number for GSK plc?
The SEC file number for GSK plc is 001-15170.
Does GSK plc file annual reports under Form 20-F or Form 40-F?
GSK plc files its annual reports under cover of Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on July 31, 2025 regarding GSK plc (GLAXF).